Fulcrum Therapeutics Inc (FULC)
3.315
+0.06
(+1.69%)
USD |
NASDAQ |
Nov 05, 16:00
3.315
0.00 (0.00%)
After-Hours: 18:55
Fulcrum Therapeutics Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2020
--
Maximum
Mar 2020
--
Average
--
Median
Mar 2020
Debt to Equity Ratio Benchmarks
| Bioventus Inc | 2.539 |
| Arcturus Therapeutics Holdings Inc | 0.00 |
| Entrada Therapeutics Inc | 0.00 |
| Johnson & Johnson | 0.5096 |
| Insmed Inc | 1.975 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 294.26M |
| Total Liabilities (Quarterly) | 20.47M |
| Shareholders Equity (Quarterly) | 273.79M |
| Current Ratio | 22.07 |